Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,732.00
(
-0.23%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HS

Send PM Follow Ignore
Followers 0
Posts 26
Boards Moderated 0
Alias Born 01/04/2007

HS

Re: rfj1862 post# 48865

Saturday, 06/23/2007 1:31:50 PM

Saturday, June 23, 2007 1:31:50 PM

Post# of 257268
rfj,
DEPO has marketed products (Glumetza and Proquin) that are not blockbusters but do make money. The GERD compound will further validate AcuForm as a viable DD technology, that will be bigger than a baclofen compound!

Again, if they are able to hit a sweet pricing point between generic Gabapentin and Pregabalin and have efficacy trending towards Pregabalin then they will pick up some serious sales.

HS
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today